CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


HP:0001399: Hepatic failureHPO

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1454 Medically Tailored Meals Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D017093 Liver Failure NIH 1.00
D007676 Kidney Failure, Chronic NIH 0.41

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Meals MATTER: A Randomized Controlled Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge

The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.

NCT04351880 Heart Failure Copd Liver Failure Covid19 Diabetes Mellitus Cancer End Stage Renal Disease Other: Medically Tailored Meals
MeSH:Liver Failure Kidney Failure, Chronic
HPO:Hepatic failure

Primary Outcomes

Description: Measured through the Hospital Anxiety and Depression Scale. 0 = Minimum. 21 = Maximum. Higher score is worse outcome.

Measure: Anxiety and Depression measured through the Hospital Anxiety and Depression Scale

Time: A change in score from baseline to 60 days

Secondary Outcomes

Description: Measured through the Katz Activities of Daily Living. Minimum = 0, Maximum = 6. Higher score is better outcome.

Measure: Functional Status measured through the Katz Activities of Daily Living Scale

Time: A change in score from baseline to 60 days

Description: Measured through time of discharge through re-hospitalization or Emergency Department visit

Measure: Re-hospitalization and Emergency Department Visits

Time: 60 days from hospital discharge


HPO Nodes